CN105214005B - The oral traditional Chinese medicine powder for treating polycystic ovary syndrome - Google Patents
The oral traditional Chinese medicine powder for treating polycystic ovary syndrome Download PDFInfo
- Publication number
- CN105214005B CN105214005B CN201510763646.XA CN201510763646A CN105214005B CN 105214005 B CN105214005 B CN 105214005B CN 201510763646 A CN201510763646 A CN 201510763646A CN 105214005 B CN105214005 B CN 105214005B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- polycystic ovary
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 201000010065 polycystic ovary syndrome Diseases 0.000 title claims abstract description 26
- 239000000843 powder Substances 0.000 title claims abstract description 11
- 229940079593 drugs Drugs 0.000 claims abstract description 19
- 239000003292 glue Substances 0.000 claims abstract description 11
- 241000282994 Cervidae Species 0.000 claims abstract description 10
- 210000003284 Horns Anatomy 0.000 claims abstract description 10
- 240000002735 Cullen corylifolium Species 0.000 claims abstract description 8
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 8
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims 1
- 210000003734 Kidney Anatomy 0.000 abstract description 17
- 210000004185 Liver Anatomy 0.000 abstract description 12
- 206010036049 Polycystic ovary Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 231100000486 side effect Toxicity 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 210000000056 organs Anatomy 0.000 abstract description 3
- 235000014375 Curcuma Nutrition 0.000 abstract description 2
- 240000002123 Curcuma aromatica Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 15
- 210000004369 Blood Anatomy 0.000 description 10
- 241000668709 Dipterocarpus costatus Species 0.000 description 4
- 210000001672 Ovary Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- GKIRPKYJQBWNGO-OCEACIFDSA-N Clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 3
- 229960003608 Clomifene Drugs 0.000 description 3
- 210000001624 Hip Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 230000001737 promoting Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 210000000988 Bone and Bones Anatomy 0.000 description 2
- 108010084340 Gonadotropin-Releasing Hormone Proteins 0.000 description 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 230000002146 bilateral Effects 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 230000003389 potentiating Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 206010000059 Abdominal discomfort Diseases 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N Bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 Bromocriptine Drugs 0.000 description 1
- 241000407170 Curcuma Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000002173 Dizziness Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014698 Endocrine disease Diseases 0.000 description 1
- 206010022437 Insomnia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 108010057021 Menotropins Proteins 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000008466 Metabolic Disease Diseases 0.000 description 1
- 210000000282 Nails Anatomy 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000010433 Ovarian Cysts Diseases 0.000 description 1
- 210000004681 Ovum Anatomy 0.000 description 1
- 102100006063 PNPT1 Human genes 0.000 description 1
- 101700074882 PNPT1 Proteins 0.000 description 1
- 229940023488 Pill Drugs 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 241001446509 Psoralea Species 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 201000004384 alopecia Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 101710031899 moon Proteins 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000224 toxic side effect Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Abstract
The present invention relates to the traditional Chinese powder medicine prepared using Chinese herbal medicine as raw material, the oral traditional Chinese medicine powder of specifically a kind for the treatment of polycystic ovary syndrome.According to parts by weight, it is made of following Chinese medicine materials：10-15 parts of radix rehmanniae preparata, 10-15 parts of deer horn glue, 5-9 parts of radix dipsaci, 5-9 parts of Cortex Eucommiae, 5-9 parts of rhizome of chuanxiong, 5-9 parts of Radix Angelicae Sinensis, 5-8 parts of Radix Paeoniae Alba, 5-8 parts of psoralea corylifolia, 7-10 parts of rhizoma cyperi, 7-10 parts of Radix Curcumae, 7-10 parts of Radix Notoginseng, 7-10 parts of curcuma zedoary.This medicine not only plays the role for the treatment of both manifestation and root cause of disease to polycystic ovary, but also can be fully adjusted each organ of human body, its function is enable normally to play, and especially has stronger effect of tonifying the liver and kidney；This medicine is without any side effects and significant in efficacy, compensates for blank of the Chinese patent drug in treatment Stein-Leventhal syndrome.
Description
Technical field
The present invention relates to the traditional Chinese powder medicine prepared using Chinese herbal medicine as raw material, specifically a kind for the treatment of polycystic ovary syndrome
Oral traditional Chinese medicine powder.
Background technique
Polycystic ovary is disease caused by the endocrine and metabolic disorder of a kind of common complexity of Women in menopause, mainly
It is classical symptom that irregular menstruation, amenorrhoea, No-clay weak interbed, crinosity, obesity, the increase of infertile and bilateral ovaries, which are shown as, in Cystic changes.
Currently, for polycystic ovary syndrome treatment mainly based on western medicine and medical practitioners, and doctor trained in Western medicine mainly passes through drug
Treatment and hormone therapy, including (1) Clomifene, (2) Clomifene and chorionic gonadotrophin (HCG) share, (3) glucocorticoid and chlorine
Meter Fen shares, (4) menotropins, (5) gonadotropin-releasing hormone (GRH), (6) FSH, (7) bromocriptine etc., Western medicine with effect
Fruit is rapidly but side effect is also very big, such as Clomifene：It is the choice drug of PCOS, ovulation rate is 60%~80%, pregnancy rate 30%~
50%, after taking this medicine, ovary increases (13.6%) because of overstimulation, vasodilation and have a gust thermal sensation (10.4%), abdominal discomfort
(5.5%), eye-blurred (1.5%) or there are the side effects such as fash and slight alopecia.Chinese medicine mainly has according to different people different
Constitution carries out Selection drug, and the most mouthfeel of decoction used is bad and not portable, at present still not dedicated for the more capsule ovum for the treatment of
The Chinese patent drug of nest syndrome.
Summary of the invention
Present invention seek to address that treating the above problem existing for the drug of polycystic ovarian disease at present, and provide a kind for the treatment of
The oral traditional Chinese medicine powder of polycystic ovary syndrome, this medicine not only play the role for the treatment of both manifestation and root cause of disease to polycystic ovary, but also can be comprehensively
Each organ of human body is adjusted, its function is enable normally to play, especially there is stronger effect of tonifying the liver and kidney；This medicine is without any poison
Side effect and significant in efficacy compensates for blank of the Chinese patent drug in treatment Stein-Leventhal syndrome.
The technical solution used to solve the technical problems of the present invention is that：
A kind of oral traditional Chinese medicine powder that treating polycystic ovary syndrome is made of following Chinese medicine materials according to parts by weight：
10-15 parts of radix rehmanniae preparata, 10-15 parts of deer horn glue, 5-9 parts of radix dipsaci, 5-9 parts of Cortex Eucommiae, 5-9 parts of rhizome of chuanxiong, 5-9 parts of Radix Angelicae Sinensis, 5-8 parts of Radix Paeoniae Alba,
5-8 parts of psoralea corylifolia, 7-10 parts of rhizoma cyperi, 7-10 parts of Radix Curcumae, 7-10 parts of Radix Notoginseng, 7-10 parts of curcuma zedoary.
Preferably, according to parts by weight, it is made of following Chinese medicine materials：12.5 parts of radix rehmanniae preparata, 12.5 parts of deer horn glue, radix dipsaci 7
Part, 7 parts of Cortex Eucommiae, 7 parts of rhizome of chuanxiong, 7 parts of Radix Angelicae Sinensis, 6.5 parts of Radix Paeoniae Alba, 6.5 parts of psoralea corylifolia, 8.5 parts of rhizoma cyperi, 8.5 parts of Radix Curcumae, Radix Notoginseng 8.5
Part, 8.5 parts of curcuma zedoary.
Preparation method：Using the glue product of the root of pure natural Chinese herbal medicine, rhizome, seed and animal drugs, through over cleaning,
The techniques such as drying are smashed Chinese medicine with medicinal herb grinder under the environmental condition of bacteria-and dust-free respectively, are then crossed 120 meshes, are pressed
It is mixed according to certain proportion, also can be processed into tablet, pill or granule.
Chinese medicine of the present invention, according to the etiology and pathology that polycystic ovary syndrome generates, in line with tonifying the liver and kidney, benefiting essence-blood is invigorated blood circulation
Stagnation resolvation, resolving hard lump improve human body comprehensively, differentiate actual situation, have benefit to have and rush down, righting and eliminating evil, eliminating evil are not hurt just, Quan Fang
The composite treatment principle of position treatment polycystic ovary syndrome, reasonable compatibility.Wherein, radix rehmanniae preparata, deer horn glue are monarch drug in a prescription；Radix dipsaci, Cortex Eucommiae,
Rhizome of chuanxiong, when being classified as ministerial drug；Radix Paeoniae Alba, psoralea corylifolia are adjutant；Rhizoma cyperi, Radix Curcumae, Radix Notoginseng, curcuma zedoary are to make medicine.
Prescription and side's justice parsing：
Radix rehmanniae preparata, Radix Paeoniae Alba-tonifying kidney and benefiting sperm：Radix rehmanniae preparata Radix Paeoniae Alba nourishing kidney yin, facilitates the generation of negative essence, while passing through enriching yin
Kidney-replenishing.
Deer horn glue, psoralea corylifolia-warming and invigorating kidney Yang, treating YIN within YANG：Deer horn glue, psoralea corylifolia temperature nourishing liver and kidney sun, especially deer horn
Glue has the function of Wen Yang and benefiting essence-blood.
Radix dipsaci, Cortex Eucommiae-tonifying liver and kidney and strengthening bones and muscles：Radix dipsaci, Cortex Eucommiae have the function of tonifying liver and kidney and strengthening bones and muscles.
Radix Notoginseng, curcuma zedoary-activating microcirculation and removing stasis medicinal, eliminating stagnation to stop pain：Radix Notoginseng has promoting blood circulation without staying the stasis of blood, stagnation resolvation without hurting positive effect,
Curcuma zedoary has the function of that dissipating blood stasis with potent drugs, Papillary can effectively eliminate the tumour of stasis in ovary.
Rhizoma Chuanxiong, Radix Angelicae Sinensis-blood circulation promoting nourishes blood：Szechuan lovage rhizome-angelica has the function of activating microcirculation and removing stasis medicinal, and has the function of that blood-nourishing is enriched blood.
Rhizoma cyperi, Radix Curcumae-dispersing stagnated hepatoqi, eliminating stasis and resolving masses：Rhizoma cyperi Radix Curcumae has good blood-activating and qi-promoting, the work of eliminating stagnation to stop pain
With again i.e. combing irritability adjusts the gas of the whole body.
The treatment of polycystic ovary patient is the slow process of comparison.Chinese medicine of the present invention is invigorated blood circulation by tonifying the liver and kidney
Stagnation resolvation and the adjustment effect for playing whole body, and then keep ovarian function recovery normal, ovarian cyst disappears, so Chinese medicine of the present invention is
A kind of good medicine for treating polycystic ovary.After polycystic ovary syndrome patient takes 1-2 course for the treatment of of Chinese medicine of the present invention（One course for the treatment of is
Three months）, the effective component in drug is able to fully play and could tumour slowly be disappeared, and ovarian function is gradually recovered just
Often, polycystic ovary is fundamentally treated, human body is made to achieve the purpose that health.
Compared with prior art, Chinese medicine of the present invention has the following advantages that：
（1）Treating both manifestation and root cause of disease；Its strengthening vital QI to eliminate pathogenic factors, eliminating evil have broken many drugs one not dissipating blood stasis with potent drugs, softening hard masses without hurting just
Dissipating bind, so that evil do not dispel and just first hurt.
（2）Animal and plant medicine effectively combines, and can preferably tonify the liver and kidney, especially warming and invigorating kidney Yang, adjusts internal organs, balance yin
Sun.
（3）It is fewer but better with drug, it is with strong points, it is truly realized with a definite target in view, searches for the primary cause of disease in treatment.
（4）Medicinal peace does not have dependence, can be discontinued, be not easy at any time when patient body is got well, and needs to be discontinued
Recurrence.
The therapeutic effect of Chinese medicine of the present invention：
This medicine of applicant's clinical application nearly 3 years, the patient of 120 Stein-Leventhal syndromes has been treated, has been mostly to arrive for 25 years old
35 years old married femles, these patient's tcm diagnosis are caused by liver and kidney deficiency, and the deficiency of blood presss from both sides stasis of blood type, and symptom mainly has weight gain, the moon
Measured that few color is dark or amenorrhoea, soreness of waist pain in the loins is vexed out of strength, the purple dark whitish tongue of tongue, and small and wiry pulse is puckery.Two courses for the treatment of of this medicine are taken, often
A course for the treatment of 3 months, symptom completely disappears, and biochemical analysis is normally recovery from illness totally 49, accounts for the 41% of sum；Symptom disappears life substantially
Change and check close to being normally effectively totally 56, accounts for the 46% of sum；Wherein there are 15 people to fail to adhere to that medication is abandoned treating, it is total effective
Rate is 87%.
Compared with the drug of other treatment polycystic ovary syndromes, the effect of Chinese medicine of the present invention is mainly reflected in：
（1）Start with from the morbidity root of polycystic ovary, while being directed to complication and developing, it is exquisite to gimmick with medicine, be
It unites and comprehensive, warming Yang, enlivening spleen, tonifying kidney and benefiting sperm, activating microcirculation and removing stasis medicinal, resolving hard lump.
（1）In line with tonifying the liver and kidney, recuperating qi-blood adjusts immunity, improves whole body function, improves qi-blood circulating.
（3）It is convenient to take, it has no toxic side effect, drug action is lasting, uneasy to recur.
Specific embodiment
With reference to embodiments and typical case the invention will be further described, purpose, which is only that, more fully understands this hair
Bright content.Therefore, the cited case is not intended to limit protection scope of the present invention.
Typical case：Liu, female, 27 years old, people from Shanxi got married 3 years and does not practise contraception and unpregnancy, weight gain about 12 over nearly 4 years
Kilogram, only intramuscular injection Western medicine menstruation can just arrive, and measure less, and Visual quality bilateral ovaries increase, and are diagnosed as polycystic ovary
Syndrome, takes Chinese and Western medicine, does not obtain expected therapeutic effect.Existing patient：Amenorrhoea is infertile, and body is fat, dizzy, vexed insomnia,
Soreness of waist pain in the loins, walking is powerless, and nail recess, the dimly pale tongue stasis of blood is purple, and tongue fur is thin white, and small and wiry pulse is puckery, again by powerless.It distinguishes as liver deficiency of the kidney
Void, the deficiency of blood press from both sides stasis syndrome.Treatment：It is nourishing liver and kidney, blood circulation promoting nourishes blood.
Prescription：By one day medication meter, it is made of following Chinese medicine materials：Radix rehmanniae preparata 1.25g, deer horn glue 1.25g, radix dipsaci
0.7g, Cortex Eucommiae 0.7g, rhizome of chuanxiong 0.7g, Radix Angelicae Sinensis 0.7g, Radix Paeoniae Alba 0.65g, psoralea corylifolia 0.65g, rhizoma cyperi 0.85g, Radix Curcumae 0.85g, three
Seven 0.85g, curcuma zedoary 0.85g amount to 10g.
Instructions of taking：The above drug breaks into fine powder, takes for every natural gift 2-3 times（After meal）, three months as a treatment course.
Further consultation after three months：Patient does not have to take Western medicine and can be in the period but is measured still seldom darker through color, and mood is obvious
It improves, waist is no longer ached, and sleep improves, the dark whitish tongue small and wiry pulse of pale tongue.
Continue to take top after three months, all goes well, be discontinued.Follow-up patient is pregnant 25 weeks after 1 year.
Claims (2)
1. a kind of oral traditional Chinese medicine powder for treating polycystic ovary syndrome, which is characterized in that according to parts by weight, by following Chinese medicines
Raw material composition：10-15 parts of radix rehmanniae preparata, 10-15 parts of deer horn glue, 5-9 parts of radix dipsaci, 5-9 parts of Cortex Eucommiae, 5-9 parts of Rhizoma Chuanxiong, 5-9 parts of Radix Angelicae Sinensis,
5-8 parts of Radix Paeoniae Alba, 5-8 parts of psoralea corylifolia, 7-10 parts of rhizoma cyperi, 7-10 parts of Radix Curcumae, 7-10 parts of Radix Notoginseng, 7-10 parts of curcuma zedoary.
2. the oral traditional Chinese medicine powder for the treatment of polycystic ovary syndrome according to claim 1, which is characterized in that by weight
Number meter, is made of following Chinese medicine materials：12.5 parts of radix rehmanniae preparata, 12.5 parts of deer horn glue, 7 parts of radix dipsaci, 7 parts of Cortex Eucommiae, 7 parts of Rhizoma Chuanxiong, Radix Angelicae Sinensis
7 parts, 6.5 parts of Radix Paeoniae Alba, 6.5 parts of psoralea corylifolia, 8.5 parts of rhizoma cyperi, 8.5 parts of Radix Curcumae, 8.5 parts of Radix Notoginseng, 8.5 parts of curcuma zedoary.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510763646.XA CN105214005B (en) | 2015-11-11 | 2015-11-11 | The oral traditional Chinese medicine powder for treating polycystic ovary syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510763646.XA CN105214005B (en) | 2015-11-11 | 2015-11-11 | The oral traditional Chinese medicine powder for treating polycystic ovary syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105214005A CN105214005A (en) | 2016-01-06 |
| CN105214005B true CN105214005B (en) | 2018-11-23 |
Family
ID=54983517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510763646.XA Expired - Fee Related CN105214005B (en) | 2015-11-11 | 2015-11-11 | The oral traditional Chinese medicine powder for treating polycystic ovary syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105214005B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511889A (en) * | 2016-10-25 | 2017-03-22 | 孙光周 | Traditional Chinese medicine potion for mainly treating follicular maldevelopment caused by polycystic ovary and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102319405A (en) * | 2011-09-30 | 2012-01-18 | 张鸿翔 | Traditional Chinese medicine composition for treating polycystic ovary syndrome |
| CN103272144A (en) * | 2013-05-24 | 2013-09-04 | 孙炳云 | Medicine for treating polycystic ovarian syndrome |
| CN104940740A (en) * | 2015-07-01 | 2015-09-30 | 袁明圆 | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof |
-
2015
- 2015-11-11 CN CN201510763646.XA patent/CN105214005B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102319405A (en) * | 2011-09-30 | 2012-01-18 | 张鸿翔 | Traditional Chinese medicine composition for treating polycystic ovary syndrome |
| CN103272144A (en) * | 2013-05-24 | 2013-09-04 | 孙炳云 | Medicine for treating polycystic ovarian syndrome |
| CN104940740A (en) * | 2015-07-01 | 2015-09-30 | 袁明圆 | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 中西医结合治疗多囊卵巢综合征63例;孙燕;《现代中西医结合杂志》;20080430;第17卷(第11期);1680-1681 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105214005A (en) | 2016-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988703B (en) | Traditional Chinese medicine preparation for treating kidney-yang deficiency and preparation method thereof | |
| CN1669577A (en) | Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof | |
| CN104162094B (en) | A kind of Chinese medicine composition and its pharmaceutical preparation for treating Obesity-type Polycystic Ovary Syndrome | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN101002873B (en) | Medicine for treating recurrent gout, and its preparing method | |
| CN105214005B (en) | The oral traditional Chinese medicine powder for treating polycystic ovary syndrome | |
| CN102247519A (en) | Formula of traditional Chinese medicine for treating rheumatoid arthritis | |
| CN102512560B (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN102302633B (en) | Chinese medicinal composition for treating woman metrorrhagia and preparation method thereof | |
| CN106620133A (en) | Medicinal liquor having functions of invigorating the kidney, strengthening Yang and expelling wind-damp and preparation method thereof | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN104906526A (en) | Chinese medicine preparation for premature ovarian failure and preparation method of Chinese medicine preparation | |
| CN110141656A (en) | A kind of Fuke Tiaojing blood-nourishing Chinese medicine composition and preparation method thereof | |
| CN104208640A (en) | Traditional Chinese medicine composition for treating delayed menstrual cycle | |
| CN106728640A (en) | It is a kind of to treat the Chinese medicine composition that irregular menstruation promotes pregnancy | |
| CN1861119B (en) | Traditional Chinese medicine for treating rheumatosis and its preparation method | |
| CN104771634A (en) | Medicine for treating coagulated cold vessel impediment type osteoporosis and preparation method thereof | |
| CN100581578C (en) | Chinese traditional medicine capsule for healing neuropathic pain and preparing process technique thereof | |
| CN104491114A (en) | Novel application of traditional Chinese medicine composition | |
| CN103784931B (en) | A kind of Chinese medicine composition for the treatment of gynecological disease | |
| CN110327440A (en) | A kind of drug and preparation method thereof for treating gout | |
| CN103446571A (en) | Drug for dispelling dampness and losing weight | |
| CN102302628A (en) | Medicament for treating lumbocrural pains and preparation method thereof | |
| CN109846973A (en) | The Chinese medicine composition for preventing and treating facioplegia | |
| CN114515321A (en) | Yang-warming and uterus-warming paste formula and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181123 Termination date: 20191111 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |